ArticlePloS one2026
Retraining gait in Parkinson's Disease via a personalised app: A study protocol.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06941779 (CuePD), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
CuePD: Investigating the Effect of Personalised Auditory Cueing on Gait in Parkinson's Disease
Who cites it
1 citing paper in PubMed.
- A Digital Cueing Intervention for Parkinsonian Gait: Laboratory-Based Clinical Validation and Acute Gait Responses.Journal of medical systems · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parkinson's disease (PD) is a progressive neurological disorder that often leads to gait impairments and an increased risk of falls, negatively impacting quality of life. Inertial-based wearables have extended gait evaluation beyond clinical settings, but their technical integration and general accessibility hinder widespread adoption. Smartphones, equipped with inertial sensors, present a scalable approach for gait assessment and retraining/rehabilitation. Auditory cueing, specifically music, has shown promise to retrain gait, yet its use and uptake is often limited by a lack of personalisation. This paper outlines an exploratory and experimental protocol to evaluate CuePD, a smartphone application/app that delivers near real-time gait assessment and personalised auditory cues (including music) for gait retraining in people with PD (PwPD). The protocol characterises beneficial and non-beneficial responses to different cueing strategies and presents separate analysis for the technical validation and gait response outcomes to reduce interpretive ambiguity between measurement performance and behavioural effects. Specifically, the protocol presents: 1) validation of CuePD's spatio-temporal gait characteristics in a controlled laboratory setting; 2) process to understand the usefulness of various auditory cues (metronome beats, instrumental music, and vocal music) to improve gait stability (i.e., increase gait speed and stride length while reducing gait variability); 3) evaluation of acceptance and preference of PwPD for personalised music cues; and 4) relationship between PwPD's musicality and their ability to adhere to auditory cues. Findings from the study will inform the suitability of gait retraining via smartphone-based app technology, personalised to the individual. Personalisation (gait characteristics and music) may potentially encourage long-term engagement for gait retraining which could lead to reduce falls and improved quality of life for PwPD. By explicitly accounting for individual variability, this protocol aims to clarify for whom and under what conditions auditory cueing is appropriate. Future work should systematically evaluate this approach as responses to auditory and/or music-based cueing in PwPD are heterogeneous with possible neutral or adverse effects, e.g., cognitive overload or exacerbation of freezing. This trial is registered at ClinicalTrials.gov (NCT06941779).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.